US 11529314
Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents
granted A61KA61K31/395A61K31/519
Quick answer
US patent 11529314 (Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents) held by The Board of Regents of the University of Texas System expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/395, A61K31/519, A61K31/573, A61K31/713